Apriem Advisors’s Sanofi SNY Stock Holding History

Apriem Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-600	Closed	-$24K	–	340
2018 Q2	$24K	Buy	+600	New	+$23.6K	0.01%	329
2017 Q2	–	Sell	-588	Closed	-$27K	–	476
2017 Q1	$27K	Buy	588 +88	+18%	+$3.73K	0.01%	303
2016 Q4	$20K	Hold	500	–	–	0.01%	354
2016 Q3	$19K	Hold	500	–	–	0.01%	337
2016 Q2	$21K	Hold	500	–	–	0.01%	335
2016 Q1	$20K	Buy	500 +100	+25%	+$4.02K	0.01%	314
2015 Q4	$17K	Hold	400	–	–	0.01%	321
2015 Q3	$19K	Hold	400	–	–	0.01%	302
2015 Q2	$20K	Buy	400 +150	+60%	+$7.6K	0.01%	329
2015 Q1	$12K	Buy	+250	New	+$12K	﹤0.01%	393
2014 Q4	–	Sell	-360	Closed	-$20K	–	548
2014 Q3	$20K	Buy	360 +320	+800%	+$17.2K	0.01%	303
2014 Q2	$2K	Buy	+40	New	+$2.12K	﹤0.01%	441

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Apriem Advisors's SNY Position: Q3 2018 in Review

Apriem Advisors sold out of Sanofi (SNY) in Q3 2018, closing a stake of 600 shares — an estimated $24K sold.

Apriem Advisors first reported a position in SNY in Q2 2014 and held it in 12 quarters. The position peaked at $27K in Q1 2017. 480 funds tracked by Wall St. Rank hold SNY as of Q3 2018.

Apriem Advisors reported no remaining Sanofi position as of Q3 2018 after selling out during the quarter.
Apriem Advisors sold 600 Sanofi shares in Q3 2018, an estimated $24K.
Apriem Advisors first reported a position in Sanofi in Q2 2014 and held it in 12 quarters.
Apriem Advisors's Sanofi position peaked at $27K in Q1 2017.
480 funds tracked by Wall St. Rank held Sanofi as of Q3 2018.

Based on Apriem Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.